Geode Capital Management, LLC Corbus Pharmaceuticals Holdings, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.11 - $5.46 $258 - $12,814	-2,347 Reduced 0.24%	986,072 $108,000
Q2 2022 Aug 12, 2022	SELL	$0.21 - $0.53 $16,456 - $41,531	-78,362 Reduced 7.35%	988,419 $249,000
Q1 2022 May 13, 2022	SELL	$0.32 - $0.67 $104,677 - $219,167	-327,116 Reduced 23.47%	1,066,781 $566,000
Q4 2021 Feb 11, 2022	BUY	$0.6 - $1.11 $4,673 - $8,645	7,789 Added 0.56%	1,393,897 $858,000
Q3 2021 Nov 12, 2021	BUY	$1.01 - $1.82 $28,945 - $52,159	28,659 Added 2.11%	1,386,108 $1.41 Million
Q2 2021 Aug 13, 2021	SELL	$1.39 - $2.21 $347,600 - $552,659	-250,072 Reduced 15.56%	1,357,449 $2.48 Million
Q1 2021 May 12, 2021	BUY	$1.27 - $3.42 $265,088 - $713,860	208,731 Added 14.92%	1,607,521 $3.17 Million
Q4 2020 Feb 12, 2021	BUY	$0.94 - $1.89 $126,719 - $254,787	134,808 Added 10.67%	1,398,790 $1.75 Million
Q3 2020 Nov 13, 2020	BUY	$1.5 - $9.38 $479,419 - $3 Million	319,613 Added 33.84%	1,263,982 $2.28 Million
Q2 2020 Aug 13, 2020	SELL	$4.79 - $8.39 $221,384 - $387,769	-46,218 Reduced 4.67%	944,369 $7.92 Million
Q1 2020 May 14, 2020	BUY	$3.44 - $7.21 $724,574 - $1.52 Million	210,632 Added 27.01%	990,587 $5.19 Million
Q4 2019 Feb 13, 2020	BUY	$4.29 - $5.64 $144,757 - $190,310	33,743 Added 4.52%	779,955 $4.26 Million
Q3 2019 Nov 12, 2019	BUY	$4.87 - $7.08 $246,115 - $357,801	50,537 Added 7.26%	746,212 $3.63 Million
Q2 2019 Aug 14, 2019	BUY	$6.6 - $7.8 $421,086 - $497,647	63,801 Added 10.1%	695,675 $4.82 Million
Q1 2019 May 14, 2019	BUY	$5.76 - $8.95 $513,515 - $797,910	89,152 Added 16.43%	631,874 $4.39 Million
Q4 2018 Feb 13, 2019	BUY	$5.26 - $7.97 $150,341 - $227,798	28,582 Added 5.56%	542,722 $3.17 Million
Q3 2018 Nov 13, 2018	BUY	$4.65 - $7.95 $97,975 - $167,506	21,070 Added 4.27%	514,140 $3.88 Million
Q2 2018 Aug 14, 2018	BUY	$5.05 - $6.8 $400,257 - $538,961	79,259 Added 19.15%	493,070 $2.49 Million
Q1 2018 May 15, 2018	BUY	$5.6 - $9.25 $24,897 - $41,125	4,446 Added 1.09%	413,811 $2.52 Million
Q4 2017 Feb 13, 2018	BUY	$6.6 - $7.78 $250,760 - $295,593	37,994 Added 10.23%	409,365 $2.91 Million
Q3 2017 Nov 14, 2017	BUY	$5.75 - $7.75 $508,926 - $685,944	88,509 Added 31.29%	371,371 $2.66 Million
Q2 2017 Aug 14, 2017	BUY	N/A	282,862	282,862 $1.78 Million

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$559,757
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$44,016
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$38,402
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account